New Key Statistics Module, Z-Score and F-Score
SZSE:300142 Key Ratios
Market Cap ¥ M | 16,329.35 |
Enterprise Value ¥ M | 13,101.51 |
P/E(ttm) | 62.64 |
PE Ratio without NRI | 23.10 |
Forward PE Ratio | 20.84 |
Price/Book | 1.75 |
Price/Sales | 4.19 |
Price/Free Cash Flow | 3,403.34 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.02 |
Revenue (TTM) ¥ M | 3,880.00 |
EPS (TTM) ¥ | 0.16 |
Beneish M-Score | -2.77 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 4.10 |
y-y EBITDA Growth Rate % | -62.00 |
EV-to-EBIT | 28.89 |
EV-to-EBITDA | 28.89 |
PEG | 5.63 |
Shares Outstanding M | 1,599.35 |
Net Margin (%) | 6.74 |
Operating Margin % | 24.83 |
Pre-tax Margin (%) | 11.48 |
Quick Ratio | 2.48 |
Current Ratio | 2.85 |
ROA % (ttm) | 1.68 |
ROE % (ttm) | 2.78 |
ROIC % (ttm) | 8.14 |
Dividend Yield % | 0.10 |
Altman Z-Score | 3.51 |
SZSE:300142 Number of Guru Trades
SZSE:300142 Volume of Guru Trades
Gurus Latest Trades with SZSE:300142
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300142 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Walvax Biotechnology Co Ltd Insider Transactions
No Available Data